| MESA+ symposium |
|
|
|
| Monday, 07 September 2009 12:44 |
|
|
| Last Updated on Wednesday, 23 December 2009 15:26 |
MagnaMedics at 3rd European Conference for Clinical Nanomedicine, Basel.
The European Foundation for Clinical Nanomedicine is a non-profit institution aiming at advancing... Read more...
The European Foundation for Clinical Nanomedicine is a non-profit institution aiming at advancing... Read more...
Vacancy: Sales Manager - IVD
To meet the demand for our fast growing product line in in-vitro Diagnostics we are seeking for our... Read more...
To meet the demand for our fast growing product line in in-vitro Diagnostics we are seeking for our... Read more...
MagSi protein A and G beads for high yield target protein purification.
Protein A and protein G are recombinant proteins that bind with high affinity to the Fc portion of... Read more...
Protein A and protein G are recombinant proteins that bind with high affinity to the Fc portion of... Read more...
MagnaMedics participates in EuroNanoMedicine (Bled, Slovenia).
MagnaMedics’CSO Paul Borm was member of the scientific committee of the EuroNanoMedicine meeting... Read more...
MagnaMedics’CSO Paul Borm was member of the scientific committee of the EuroNanoMedicine meeting... Read more...
Buy Magnetic Beads
Read our 



MagnaMedics' CSO/CEO Paul Borm spoke at MESA+ annual internal symposium at the Grolsch Veste (the soccer stadium!), Colosseum 65 in Enschede (NL) on Monday 21 September 2009. He spoke about the benefits and risks of different nanoparticles in Life Sciences, thereby using MagnaMedics technologies (e.g. imaging and drug delivery) as examples. More info: